BioSpace News Archive

GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors.

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, will give an oral presentation on its lead clinical candidate, PMN310 for Alzheimer’s disease,

Kroger Health, the healthcare arm of The Kroger Co. providing health, wellness, and nutrition solutions to more than 14 million people nationwide, announced its partnership with Myriad Genetics to pilot Myriad Genetics’ GeneSight® pharmacogenomic test with Kroger Health Plan members.

Company to establish new subsidiary office in Liege, Belgium

Surplus medical equipment company Centurion Service Group acquires equipment re-furbisher and retailer Ganim Medical to offer hospitals strategic partnership in the equipment liquidation process

POMALYST®, in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple myeloma

Product candidates have repeated significant yield improvement in second year spring wheat field trials across multiple locations, varieties and conditions

Ortho to Host Industry Conferences: ‘Lab Leader Summit’ and ‘Healthcare Management in a Digital World’

Orexo AB announces the company has signed an agreement granting Mundipharma Pty Limited the exclusive rights to commercialize Orexo’s lead product, Zubsolv®, for the treatment of opioid dependence, in Australia and New Zealand.

Dr. Reddy’s Laboratories Ltd. will announce results for the first quarter ended June 30, 2019 on Monday, July 29, 2019 after the Board Meeting.